Omnicell closed at $35.46 on Nov 3, down 2.61%, 31.0% below its 52-week closing high. Volume of 890.8K shares was 1.57× its 20-day average (above normal).
Split-adjusted performance: +2.4% over one month, -18.6% over six months, +5.6% over one year.
In the quarter ended Jun 30, 2026, revenue was $312.21M, up 7.4% from a year earlier, with a net margin of 7.8%.
Short interest was 3.3M shares at the Oct 15 settlement, down 10.3% from the prior report (7.4% of float, 7.5 days to cover).